We are valued at 63 mill cap for proven data and ground breaking antibiotic discoveries in both gram positive and gram negative environments.
BTX1503 was a whisker away from complete success.
We have experienced blokes with FDA experience.
We have cash in the bank.
I'd say we have seen the bottom.
The money on the sidelines will be itching to return as EOFY approaches and the current trial comes to an end.
This surely has to be one of the most insane bio plays on the market.
There are companies valued at $90 mill cap with only animal trials - fair dinkum.
BOT - Anything but charting, page-2622
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.8¢ |
Change
-0.008(1.81%) |
Mkt cap ! $725.6M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 42.5¢ | 39.5¢ | $3.311M | 8.079M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 48365 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 275050 | 10 |
View Market Depth
| Last trade - 15.31pm 17/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |